PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS. (2017). Voprosy Onkologii, 63(2), 326-328. https://doi.org/10.37469/0507-3758-2017-63-2-326-328